The roles of histone acetylation key enzymes HAT, HDAC and BET proteins in neuropathic pain: Selection of drug targets
- PMID: 40518086
- DOI: 10.1016/j.phrs.2025.107813
The roles of histone acetylation key enzymes HAT, HDAC and BET proteins in neuropathic pain: Selection of drug targets
Abstract
Histone acetylation is currently one of the epigenetic mechanisms that have been extensively and profoundly studied, and is associated with the occurrence and development of various diseases such as cancer and neurodegenerative disorders.Histone acetylation/deacetylation refers to the addition/removal of acetyl groups on histone lysine residues under the action of histone acetyltransferase (HAT)/histone deacetylase (HDAC), and is read by BET proteins, influencing gene transcription. In recent years, an increasing amount of evidence has indicated that histone acetylation plays a vital role in neuropathic pain. Neuropathic pain is an unresolved medical issue for which no effective treatment measures are available.Therefore, This article, from a novel perspective of HAT, HDAC, and BET proteins, deeply exploresthe mechanism of histone acetylation in various neuropathic pain models. The study found that HAT, HDAC, and BET proteins,at multiple levels, affect the expression of proteins such as ion channels, chemokines.and inflammatory factors through gene regulatory mechanisms. Based on this, future research can focus on the drug development targeting HAT, HDAC, and BET proteins, with the expectation of achieving more precise and effective regulation of neuropathic pain at the genetic level.
Keywords: BET; HAT; HDAC; Histone acetylation; Neuropathic pain; Proteins.
Copyright © 2025 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Contribution of histone deacetylases (HDACs) to the regulation of histone and non-histone proteins: implications for fibrotic diseases.BMB Rep. 2025 Aug;58(8):313-324. doi: 10.5483/BMBRep.2024-0122. BMB Rep. 2025. PMID: 40635201 Free PMC article. Review.
-
Oxcarbazepine for neuropathic pain.Cochrane Database Syst Rev. 2017 Dec 2;12(12):CD007963. doi: 10.1002/14651858.CD007963.pub3. Cochrane Database Syst Rev. 2017. PMID: 29199767 Free PMC article.
-
Transcutaneous electrical nerve stimulation (TENS) for neuropathic pain in adults.Cochrane Database Syst Rev. 2017 Sep 14;9(9):CD011976. doi: 10.1002/14651858.CD011976.pub2. Cochrane Database Syst Rev. 2017. PMID: 28905362 Free PMC article.
-
Antidepressants for neuropathic pain.Cochrane Database Syst Rev. 2007 Oct 17;2007(4):CD005454. doi: 10.1002/14651858.CD005454.pub2. Cochrane Database Syst Rev. 2007. PMID: 17943857 Free PMC article.
-
Antidepressants for chronic non-cancer pain in children and adolescents.Cochrane Database Syst Rev. 2017 Aug 5;8(8):CD012535. doi: 10.1002/14651858.CD012535.pub2. Cochrane Database Syst Rev. 2017. PMID: 28779487 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources